Product Images Candesartan Cilexetil

This is a description of Candesartan Cilexetil tablets labeled with NDC 51407-882-90. Each tablet contains 4 mg of Candesartan Cilexetil USP. The pharmacist is advised to dispense patient information to each patient and the information can be printed from the provided website. The dosage information is available in the accompanying Prescribing Information. It is important to keep the container tightly closed and store the medication at 20° - 25°C (68° - 77°F). This medication should be kept out of the reach of children. The product is marketed by GSMS, Incorporated based in Camarillo, CA 93012, USA.*

This is a description of a medication called Candesartan Cilexetil in tablet form. Each tablet contains 8 mg of Candesartan Cilexetil USP. The dosage instructions can be found in the accompanying Prescribing Information. Patients should be provided with the Patient Information available at the provided link. The medication should be stored at 20° - 25°C (68° - 77°F) and kept out of reach of children. The product is marketed by GSMS, Incorporated in Camarillo, CA, USA.*

This is a description of Candesartan Cilexetil tablets with an NDC code of 51407-884-90. Each tablet contains 16 mg of Candesartan Cilexetil USP. Patients are advised to refer to the accompanying Prescribing Information for the appropriate dosage. The medication should be stored at a temperature between 20° - 25°C (68° - 77°F), and the container should be tightly closed. The product is marketed by GSMS, Incorporated. For more patient information, visit: https://gsms.us/.*

This text provides information on a medication called Candesartan Cilexetil tablets, with each tablet containing 32 mg of Candesartan. It includes instructions for pharmacists to dispense patient information and directs patients to a website for further details. The dosage information is to be reviewed in the accompanying Prescribing Information. The medication should be stored at 20°C - 25°C and kept away from children. The medicine is produced by GSMS, Incorporated and the package contains 90 tablets. The document also mentions the importance of keeping the container tightly closed.*

This document appears to be a medical record for a patient under the age of 65. It includes information such as the patient's sex (female), race (Black), medical history (e.g., diabetes, hypertension), and current medications (e.g., aspirin). The record also contains data on a study or trial involving the medication Candesartan, with information on patients' responses and statistical analysis (e.g., hazard ratio). It seems to be related to cardiovascular health or clinical research.*